ULCERATIVE COLITIS CHRONIC
Clinical trials for ULCERATIVE COLITIS CHRONIC explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS CHRONIC trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with IBD: Long-Term drug trial launches
Disease control Recruiting nowThis study tests the long-term safety and effectiveness of mirikizumab in 150 children and adolescents with moderate-to-severe ulcerative colitis or Crohn's disease. Participants who completed earlier mirikizumab studies can join. The trial lasts about 172 weeks and aims to see i…
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a probiotic tame ulcerative colitis? early trial begins
Disease control Recruiting nowThis early-stage study is testing whether an oral probiotic called R-3750 is safe and tolerable for people with mild to moderate ulcerative colitis. About 36 adults will take the probiotic and be monitored for side effects, inflammation, and symptom changes. The goal is to see if…
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug combo aims to tame ulcerative colitis
Disease control Recruiting nowThis study tests two drugs, eltrekibart and mirikizumab, alone or together, in 140 adults with moderate-to-severe ulcerative colitis. The goal is to see if they can safely reduce inflammation and help patients achieve remission. Participants must have tried other treatments witho…
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC